DELFI DIAGNOSTICS
Delfi Diagnostics detect cancer early, when it is most curable, using high precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients.
DELFI DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2019-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.delfidiagnostics.com
Total Employee:
101+
Status:
Active
Contact:
410-696-3304
Email Addresses:
[email protected]
Total Funding:
330.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Nginx Sitelinks Search Box
Similar Organizations
![]()
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Juno Diagnostics
Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.
LightDeck Diagnostics
LightDeck is a developer of on-the-spot diagnostic products used to offer fast, accurate, simple, and low-cost diagnostic tests.
Current Advisors List
![]()
![]()
Current Employees Featured
![]()

Founder
![]()
Investors List
PTX Capital
PTX Capital investment in Series B - Delfi Diagnostics
Northpond Ventures
Northpond Ventures investment in Series B - Delfi Diagnostics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Delfi Diagnostics
![]()
Brown Advisory
Brown Advisory investment in Series B - Delfi Diagnostics

Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Delfi Diagnostics
Foresite Capital
Foresite Capital investment in Series B - Delfi Diagnostics

Point Field Partners
Point Field Partners investment in Series B - Delfi Diagnostics
![]()
OrbiMed
OrbiMed investment in Series B - Delfi Diagnostics
![]()
Rock Springs Capital
Rock Springs Capital investment in Series B - Delfi Diagnostics
![]()
T. Rowe Price
T. Rowe Price investment in Series B - Delfi Diagnostics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-12 | Jessica Meng Joins Delfi Diagnostics as Chief Commercial Officer |
| 2021-10-07 | Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer |
Official Site Inspections
http://www.delfidiagnostics.com Semrush global rank: 3.55 M Semrush visits lastest month: 4.11 K
- Host name: ec2-35-82-237-120.us-west-2.compute.amazonaws.com
- IP address: 35.82.237.120
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
